BRIDGE LOAN AGREEMENT Dated as of September 30, 2022Bridge Loan Agreement • November 8th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 8th, 2022 Company Industry JurisdictionSorrento Therapeutics, Inc., a Delaware corporation (the “Borrower”), and B. Riley Commercial Capital, LLC (the “Lender”) agree as follows:
BRIDGE LOAN AGREEMENT Dated as of February 16, 2022Bridge Loan Agreement • May 5th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 5th, 2022 Company Industry JurisdictionSorrento Therapeutics, Inc., a Delaware corporation (the “Borrower”), and B. Riley Commercial Capital, LLC (the “Lender”) agree as follows: